Detection of PTEN Immunoreactivity in Endometrial Hyperplasia and Adenocarcinoma
作者： Prasert Trivijitsilp , Surang Triratanachat , Patou Tantbirojn , Somchai Niruthisard
DOI:
关键词:
摘要: PTEN protein expression was evaluated by immunohistrochemical study of 70 paraffin-embedded curettage endometrial tissue samples (10 normal endometrium, 55 hyperplasia, and15 adenocarcinomas) selected from surgical pathology files the Division GynecologicPathology, Department Obstetrics and Gynecology, Faculty Medicine, Chulalongkorn University, from2001 to 2004. Intensity epithelial staining immunoreactivity in different histologic types wasdetermined.
researchgate.net 参考文章(19)
K R Cho, T D Kessis, L Hedrick, R T Burks, Microsatellite instability in endometrial carcinoma. Oncogene. ,vol. 9, pp. 1163- 1166 ,(1994)
Marian S. Blazes, Kathleen R. Cho, Steven I. Wang, Ramon Parsons, Shikha Bose, Lora Hedrick Ellenson, Hironori Tashiro, Jing Li, Rong Wu, Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Research. ,vol. 57, pp. 3935- 3940 ,(1997)
Andrew Berchuck, John I. Risinger, J. Carl Barrett, A. Kate Hayes, PTEN/MMAC1 Mutations in Endometrial Cancers Cancer Research. ,vol. 57, pp. 4736- 4738 ,(1997)
Gregory S. Buzard, Osamu Tanizawa, Alan O. Perantoni, Jerry M. Rice, Takayuki Enomoto, Hiroshi Miki, Masaki Inoue, K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Research. ,vol. 51, pp. 5308- 5314 ,(1991)
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, M. J. Thun, Cancer statistics, 2007. CA: A Cancer Journal for Clinicians. ,vol. 57, pp. 43- 66 ,(2007) , 10.3322/CANJCLIN.57.1.43
Pilar Machin, Lluis Catasus, Cristina Pons, Josefina Muñoz, Xavier Matias-Guiu, Jaime Prat, None, CTNNB1 mutations and β-catenin expression in endometrial carcinomas Human Pathology. ,vol. 33, pp. 206- 212 ,(2002) , 10.1053/HUPA.2002.30723
George L. Mutter, Pten, a protean tumor suppressor. American Journal of Pathology. ,vol. 158, pp. 1895- 1898 ,(2001) , 10.1016/S0002-9440(10)64656-1
A. Ørbo, T. Kaino, M. Arnes, M. Kopp, K. Eklo, Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up. Gynecologic Oncology. ,vol. 95, pp. 82- 88 ,(2004) , 10.1016/J.YGYNO.2004.07.024
Lars-Christian Horn, Alexandra Meinel, Romy Handzel, Jens Einenkel, Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Annals of Diagnostic Pathology. ,vol. 11, pp. 297- 311 ,(2007) , 10.1016/J.ANNDIAGPATH.2007.05.002
George L. Mutter, Ming-Chieh Lin, Jeffrey T. Fitzgerald, Jennifer B. Kum, Charis Eng, Changes in EndometrialPTENExpression throughout the Human Menstrual Cycle1 The Journal of Clinical Endocrinology & Metabolism. ,vol. 85, pp. 2334- 2338 ,(2000) , 10.1210/JCEM.85.6.6652